| Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer JD Warren, W Xiong, AM Bunker, CP Vaughn, LV Furtado, WL Roberts, ... BMC medicine 9, 1-9, 2011 | 501 | 2011 |
| Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer CP Vaughn, SD ZoBell, LV Furtado, CL Baker, WS Samowitz Genes, Chromosomes and Cancer 50 (5), 307-312, 2011 | 498 | 2011 |
| Identification of proteins from formalin-fixed paraffin-embedded cells by LC-MS/MS DK Crockett, Z Lin, CP Vaughn, MS Lim, KSJ Elenitoba-Johnson Laboratory investigation 85 (11), 1405-1415, 2005 | 167 | 2005 |
| Clinical analysis of PMS2: mutation detection and avoidance of pseudogenes CP Vaughn, J Robles, JJ Swensen, CE Miller, E Lyon, R Mao, ... Human mutation 31 (5), 588-593, 2010 | 113 | 2010 |
| Advances in detection of hemoglobinopathies DN Greene, CP Vaughn, BO Crews, AM Agarwal Clinica chimica acta 439, 50-57, 2015 | 92 | 2015 |
| High-resolution melting analysis for detection of internal tandem duplications CP Vaughn, KSJ Elenitoba-Johnson The Journal of Molecular Diagnostics 6 (3), 211-216, 2004 | 70 | 2004 |
| Avoidance of pseudogene interference in the detection of 3′ deletions in PMS2 CP Vaughn, KJ Hart, WS Samowitz, JJ Swensen Human mutation 32 (9), 1063-1071, 2011 | 51 | 2011 |
| Quantitative evaluation of CpG island methylation in hyperplastic polyps CP Vaughn, AR Wilson, WS Samowitz Modern Pathology 23 (1), 151-156, 2010 | 49 | 2010 |
| Sporadic microsatellite instability-high colon cancers rarely display immunohistochemical evidence of Wnt signaling activation NC Panarelli, CP Vaughn, WS Samowitz, RK Yantiss The American journal of surgical pathology 39 (3), 313-317, 2015 | 40 | 2015 |
| Mosaic ACVRL1 and ENG mutations in hereditary haemorrhagic telangiectasia patients DH Best, C Vaughn, J McDonald, K Damjanovich, JR Runo, JM Chibuk, ... Journal of medical genetics 48 (5), 358-360, 2011 | 39 | 2011 |
| Hybridization-induced dequenching of fluorescein-labeled oligonucleotides: a novel strategy for PCR detection and genotyping CP Vaughn, KSJ Elenitoba-Johnson The American journal of pathology 163 (1), 29-35, 2003 | 36 | 2003 |
| The frequency of previously undetectable deletions involving 3′ Exons of the PMS2 gene CP Vaughn, CL Baker, WS Samowitz, JJ Swensen Genes, Chromosomes and Cancer 52 (1), 107-112, 2013 | 34 | 2013 |
| A quantitative allele-specific PCR test for the BRAF V600E mutation using a single heterozygous control plasmid for quantitation: a model for qPCR testing without standard curves P Szankasi, NS Reading, CP Vaughn, JT Prchal, DW Bahler, TW Kelley The Journal of Molecular Diagnostics 15 (2), 248-254, 2013 | 31 | 2013 |
| Comprehensive identification of proteins in Hodgkin lymphoma-derived Reed–Sternberg cells by LC-MS/MS JC Wallentine, KK Kim, CE Seiler III, CP Vaughn, DK Crockett, SR Tripp, ... Laboratory investigation 87 (11), 1113-1124, 2007 | 31 | 2007 |
| A PIK3CA pyrosequencing-based assay that excludes pseudogene interference CL Baker, CP Vaughn, WS Samowitz The Journal of Molecular Diagnostics 14 (1), 56-60, 2012 | 29 | 2012 |
| Simultaneous detection of lung fusions using a multiplex RT-PCR next generation sequencing-based approach: a multi-institutional research study CP Vaughn, JL Costa, HE Feilotter, R Petraroli, V Bagai, AM Rachiglio, ... BMC cancer 18, 1-8, 2018 | 26 | 2018 |
| The Splicing Efficiency of Activating HRAS Mutations Can Determine Costello Syndrome Phenotype and Frequency in Cancer AM Hartung, J Swensen, IE Uriz, M Lapin, K Kristjansdottir, USS Petersen, ... PLoS genetics 12 (5), e1006039, 2016 | 25 | 2016 |
| Recurrent and founder mutations in the PMS2 gene J Tomsic, L Senter, S Liyanarachchi, M Clendenning, CP Vaughn, ... Clinical genetics 83 (3), 238-243, 2013 | 25 | 2013 |
| Analytical characteristics of cleavable isotope-coded affinity tag-LC-tandem mass spectrometry for quantitative proteomic studies CP Vaughn, DK Crockett, MS Lim, KSJ Elenitoba-Johnson The Journal of Molecular Diagnostics 8 (4), 513-520, 2006 | 24 | 2006 |
| Confirmation of single exon deletions in MLH1 and MSH2 using quantitative polymerase chain reaction CP Vaughn, E Lyon, WS Samowitz The Journal of Molecular Diagnostics 10 (4), 355-360, 2008 | 20 | 2008 |
David K. Crockett, PhDAssistant Vice President, Enterprise Analytics, Intermountain Healthcare在 utah.edu 的电子邮件经过验证
David K. Crockett, PhDAssistant Vice President, Enterprise Analytics, Intermountain Healthcare在 utah.edu 的电子邮件经过验证
Andrew WilsonUniversity of Utah在 utah.edu 的电子邮件经过验证